Busca ao vivo
O TopFind está buscando as correspondências mais recentes para a sua pesquisa.
Analisamos 5 resultados ao vivo para soliris e reduzimos para 3 opções que parecem valer mais a comparação primeiro.
Os temas mais fortes nesta lista curta são Biologics e Rare Disease Treatment.
Fonte: Alexion Pharmaceuticals
Descrição
Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system.
Melhor para
Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder e Specialized biologic therapy
Avaliação
Fonte: AstraZeneca Malaysia
Descrição
Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases.
Melhor para
Complement inhibition, Rare immune diseases e Infusion therapy
Avaliação
Fonte: AstraZeneca Malaysia
Descrição
Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA).
Melhor para
Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions e Local rare disease support
Avaliação
| Comparar | Soliris (eculizumab) | Soliris | Soliris 10mg/ml Concentrate for Solution for Infusion |
|---|---|---|---|
| Fonte | Alexion Pharmaceuticals | AstraZeneca Malaysia | AstraZeneca Malaysia |
| Descrição | Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system. | Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases. | Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA). |
| Melhor para | Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder e Specialized biologic therapy | Complement inhibition, Rare immune diseases e Infusion therapy | Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions e Local rare disease support |
| Ação | |||
| Avaliação |
Se você quer começar pela opção mais equilibrada, eu recomendo:
"Soliris (eculizumab) de Alexion Pharmaceuticals."
Eu escolhi isso porque As the original manufacturer, Alexion provides the most comprehensive safety protocols and patient support through programs like OneSource.